AZD2693
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for AZD2693, covering 2025-07-20 to 2026-02-19. Get the full timeline:
Most recent: Clinical Trial Update: A Phase I Study to Investigate the Effect of Hepatic Impairment on the PK, Safety, and Tolerability of AZD2693. [Phase 1]